𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Alpha-interferon for relapsed non-Hodgkin's lymphoma

✍ Scribed by Armitage, A E; Armitage, J D; Armitage, J O

Book ID
110015136
Publisher
Nature Publishing Group
Year
2006
Tongue
English
Weight
71 KB
Volume
38
Category
Article
ISSN
0007-1188

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Interferon therapy of non-Hodgkin's lymp
Interferon therapy of non-Hodgkin's lymphoma
✍ Kenneth A. Foon; Mark S. Roth; Paul A. Bunn Jr πŸ“‚ Article πŸ“… 1987 πŸ› John Wiley and Sons 🌐 English βš– 459 KB πŸ‘ 2 views

In 1981, the National Cancer Institute undertook Phase I1 trials of interferon alfa-2a in patients with non-Hodgkin's lymphoma (including cutaneous T-cell lymphoma [CTCL]) and chronic lymphocytic leukemia (CLL). A dose of 50 X lo6 U/m2, three times per week, was used initially, then adjusted downwar

Late relapse with nodular lymphoma after
Late relapse with nodular lymphoma after treatment for diffuse non-Hodgkin's lymphoma
✍ M. Marazuela; M. Yebra; J. A. GirΓ³n; J. L. MenΓ©ndez; J. A. Vargas; P. EspaΓ±a; M. πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 535 KB

Histologic conversion from a low-grade non-Hodgkin's lymphoma (NHL) into a more aggressive histologic pattern is a common, well-documented event in NHL. The converse phenomenon, appearance of a low-grade, follicular NHL after treatment for diffuse, intermediate, or high-grade NHL, has only recently